|
FR2564319A1
(fr)
|
1984-05-21 |
1985-11-22 |
Inst Nat Sante Rech Med |
Nouvelles compositions de liposomes dotees d'une action specifique vis-a-vis de la proliferation de cellules donnees
|
|
US4584375A
(en)
|
1984-08-21 |
1986-04-22 |
Rensselaer Polytechnic Institute |
Fluorine-containing antifolates incapable of polyglutamate formation
|
|
KR0162654B1
(ko)
|
1989-12-11 |
1998-11-16 |
알렌 제이. 시니스갤리 |
N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
|
|
EP0492316A1
(en)
|
1990-12-14 |
1992-07-01 |
Takeda Chemical Industries, Ltd. |
Condensed heterocyclic oligoglutamate derivatives, their production and pharmaceutical compositions containing them
|
|
JP3202999B2
(ja)
|
1991-01-31 |
2001-08-27 |
協和醗酵工業株式会社 |
肝移行性リポソーム製剤
|
|
US5646253A
(en)
|
1994-03-08 |
1997-07-08 |
Memorial Sloan-Kettering Cancer Center |
Recombinant human anti-LK26 antibodies
|
|
US5416211A
(en)
|
1992-09-25 |
1995-05-16 |
Eli Lilly And Company |
Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
ATE262799T1
(de)
|
1996-01-31 |
2004-04-15 |
Univ South Alabama |
Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
|
|
US20020168761A1
(en)
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US20030073640A1
(en)
|
1997-07-23 |
2003-04-17 |
Ribozyme Pharmaceuticals, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
|
ZA987550B
(en)
|
1997-09-26 |
2000-02-21 |
Lilly Co Eli |
Processes and intermediates useful to make antifolates.
|
|
US6262262B1
(en)
|
1997-09-26 |
2001-07-17 |
Eli Lilly And Company |
Processes and intermediates useful to make antifolates
|
|
US5912251A
(en)
|
1998-01-17 |
1999-06-15 |
Nair; Madhavan G. |
Metabolically inert anti-inflammatory and anti-tumor antifolates
|
|
US20050031679A1
(en)
|
1998-03-27 |
2005-02-10 |
Clemens Unger |
Method for producing liposomal formulations of active ingredients
|
|
BR9911935A
(pt)
|
1998-07-09 |
2001-04-03 |
Rhodia Chimie Sa |
Copolìmeros enxertados solúveis em água ou dispersáveis em água
|
|
US6066732A
(en)
|
1998-08-21 |
2000-05-23 |
The Trustees Of Princeton University |
Process for the preparation of pyrrolo[2,3-d]pyrimidines
|
|
WO2001005405A1
(en)
|
1999-07-16 |
2001-01-25 |
The General Hospital Corporation |
Folylpolyglutamyl synthetase gene transfer to enhance antifolate drug sensitivity
|
|
WO2001014379A2
(en)
|
1999-08-23 |
2001-03-01 |
Eli Lilly And Company |
A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
|
|
IL150480A0
(en)
|
2000-02-25 |
2002-12-01 |
Lilly Co Eli |
A NOVEL-CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4, 7-DIHYDRO-4-OXO-3H-PYRROLO[2, 3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
|
|
CN1095472C
(zh)
|
2000-04-17 |
2002-12-04 |
上海复康医药科技发展有限公司 |
叶酸-多聚糖复合物,其制备方法和以该复合物为活性成分的药物组合物
|
|
CN1446080A
(zh)
|
2000-06-09 |
2003-10-01 |
Osi药物公司 |
脂质体苯并喹唑啉胸苷酸合成酶抑制剂制剂
|
|
EP1299085B1
(en)
|
2000-06-30 |
2005-11-16 |
Inex Pharmaceuticals Corp. |
Improved liposomal camptothecins and uses thereof
|
|
WO2002002093A2
(en)
|
2000-06-30 |
2002-01-10 |
Eli Lilly And Company |
Combination containing an antifolate and methylmalonic acid lowering agent
|
|
AU2003211103A1
(en)
|
2002-02-13 |
2003-09-04 |
Northeastern University |
Intracellular delivery of therapeutic agents
|
|
CH696628A5
(de)
|
2002-02-26 |
2007-08-31 |
Eprova Ag |
Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
|
|
US7563590B2
(en)
|
2002-08-30 |
2009-07-21 |
Cypress Bioscience Inc. |
Methods of quantifying methotrexate metabolites
|
|
US6921667B2
(en)
|
2003-03-07 |
2005-07-26 |
Prometheus Laboratories, Inc. |
Methods for direct detection of individual methotrexate metabolites
|
|
EP1608337A2
(en)
|
2003-04-02 |
2005-12-28 |
Celator Technologies Inc. |
Combination compositions of camptothecins and fluoropyrimidines
|
|
NZ589967A
(en)
|
2004-01-14 |
2012-07-27 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
|
CA2556027C
(en)
|
2004-02-12 |
2015-11-24 |
Morphotek, Inc. |
Monoclonal antibodies that specifically block biological activity of a tumor antigen
|
|
US7612071B2
(en)
|
2004-03-12 |
2009-11-03 |
Syntrix Biosystems, Inc. |
Compositions and methods employing aminopterin
|
|
WO2005103250A1
(ja)
|
2004-04-26 |
2005-11-03 |
Takami Matsuyama |
葉酸リセプターベータ(FR-β)に対する単クローン抗体を含有する治療薬
|
|
KR101462825B1
(ko)
|
2004-05-03 |
2014-11-21 |
헤르메스 바이오사이언스, 인코포레이티드 |
약물 전달에 유용한 리포좀
|
|
US7695908B2
(en)
|
2004-06-15 |
2010-04-13 |
Prometheus Laboratories Inc. |
Methods for predicting methotrexate polyglutamate levels using pharmacogenetics
|
|
JP2008512490A
(ja)
|
2004-09-08 |
2008-04-24 |
チェルシー・セラピューティクス,インコーポレイテッド |
異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
|
|
US20070270431A1
(en)
|
2004-09-29 |
2007-11-22 |
Kowa Co., Ltd. |
Preventive and/or Therapeutic Medicine for Rheumatoid Arthritis
|
|
US8126089B2
(en)
|
2004-09-30 |
2012-02-28 |
Alcatel Lucent |
Method and apparatus for providing frame synchronization in a digital communication system that supports multiple modulation formats
|
|
US20100266709A1
(en)
|
2004-12-16 |
2010-10-21 |
Hicks Terry Lee |
Compositions and Methods for Treating Burns
|
|
US7687473B2
(en)
|
2005-01-07 |
2010-03-30 |
Health Research, Inc. |
5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
|
|
CA2597724A1
(en)
|
2005-02-14 |
2007-08-02 |
Sirna Therapeutics, Inc. |
Cationic lipids and formulated molecular compositions containing them
|
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
GB2424837B
(en)
|
2005-04-06 |
2010-10-06 |
Cilag Ag Int |
Injection device
|
|
MX2008002648A
(es)
*
|
2005-08-24 |
2008-03-14 |
Protherics Medicines Dev Ltd |
Escision de compuestos antifolato.
|
|
CN101365424A
(zh)
|
2005-12-08 |
2009-02-11 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
通过超声辐射改变脂质体组成的方法
|
|
WO2007098089A2
(en)
|
2006-02-17 |
2007-08-30 |
Novacea, Inc. |
Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
|
|
US9265746B2
(en)
|
2006-05-31 |
2016-02-23 |
Merck & Cie |
Method for cell-specific targeting
|
|
JP2008543975A
(ja)
|
2006-08-14 |
2008-12-04 |
シコール インコーポレイティド |
高度に純粋なペメトレキセド二酸およびその調製方法
|
|
JP2008543973A
(ja)
|
2006-08-14 |
2008-12-04 |
シコール インコーポレイティド |
ペメトレキセドの中間体の調製方法
|
|
WO2008030818A2
(en)
|
2006-09-05 |
2008-03-13 |
Mebiopharm Co., Ltd. |
Novel liposome compositions
|
|
CA2674075C
(en)
|
2006-12-29 |
2012-10-30 |
Charles P. Theuer |
Antifolate agent combinations in the treatment of cancer
|
|
RU2423114C2
(ru)
|
2006-12-29 |
2011-07-10 |
Тракон Фармасьютикалз, Инк. |
Комбинации антифолатного агента в лечении рака
|
|
AU2008206161A1
(en)
|
2007-01-19 |
2008-07-24 |
Chelsea Therapeutics, Inc. |
New classical antifolates
|
|
WO2008103276A2
(en)
|
2007-02-16 |
2008-08-28 |
Merck & Co., Inc. |
Compositions and methods for potentiated activity of biologicaly active molecules
|
|
KR20100014854A
(ko)
|
2007-04-03 |
2010-02-11 |
닥터 레디스 레보러터리즈 리미티드 |
페메트렉세드의 고체 형태
|
|
ATE556715T1
(de)
|
2008-03-18 |
2012-05-15 |
Btg Int Ltd |
Cyclopenta-äg-üchinazolin-derivate zur behandlung von arthritis oder akuter myeloischer leukämie
|
|
GB0811360D0
(en)
|
2008-06-20 |
2008-07-30 |
Imp Innovations Ltd |
Methods
|
|
WO2010021865A1
(en)
|
2008-08-18 |
2010-02-25 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
|
WO2010080724A1
(en)
|
2009-01-12 |
2010-07-15 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
|
EP2437596B1
(en)
|
2009-06-03 |
2017-05-03 |
Ex-Tek, LLC |
Skin treatment compositions
|
|
ES2613498T3
(es)
|
2009-07-01 |
2017-05-24 |
Protiva Biotherapeutics Inc. |
Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
TW201118098A
(en)
|
2009-08-13 |
2011-06-01 |
Reddy S Lab Liimited Dr |
Processes for preparing pemetrexed
|
|
US9181295B2
(en)
|
2009-08-20 |
2015-11-10 |
Sirna Therapeutics, Inc. |
Cationic lipids with various head groups for oligonucleotide delivery
|
|
US20120253032A1
(en)
|
2009-10-08 |
2012-10-04 |
Merck Sharp & Dohme Corporation |
Novel cationic lipids with short lipid chains for oligonucleotide delivery
|
|
US20130116419A1
(en)
|
2010-01-22 |
2013-05-09 |
Daniel Zewge |
Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry
|
|
CN105777907B
(zh)
|
2010-02-24 |
2020-03-17 |
伊缪诺金公司 |
叶酸受体1抗体与免疫缀合物以及其用途
|
|
SG184127A1
(en)
|
2010-03-19 |
2012-10-30 |
Massachusetts Inst Technology |
Lipid vesicle compositions and methods of use
|
|
US9770414B2
(en)
*
|
2010-05-13 |
2017-09-26 |
Pacira Pharmaceuticals, Inc. |
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
|
|
EP2394640A1
(en)
|
2010-05-21 |
2011-12-14 |
MediGene AG |
Improved liposomal formulations of lipophilic compounds
|
|
WO2011149733A2
(en)
|
2010-05-24 |
2011-12-01 |
Merck Sharp & Dohme Corp. |
Novel amino alcohol cationic lipids for oligonucleotide delivery
|
|
WO2011150392A1
(en)
|
2010-05-28 |
2011-12-01 |
Purdue Research Foundation |
Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
|
|
DK2575767T3
(en)
|
2010-06-04 |
2017-03-13 |
Sirna Therapeutics Inc |
HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES
|
|
IT1401677B1
(it)
|
2010-07-22 |
2013-08-02 |
Chemi Spa |
Nuovo processo per la sintesi di pemetrexed sale disodico
|
|
EP2449113B8
(en)
|
2010-07-30 |
2015-11-25 |
CureVac AG |
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
|
|
EP2614084A4
(en)
|
2010-09-09 |
2014-02-19 |
Purdue Research Foundation |
HUMANE FOLAT RECEPTOR BETA ANTIBODIES AND METHOD FOR THEIR USE
|
|
WO2012037068A1
(en)
|
2010-09-13 |
2012-03-22 |
De Novo Diagnostics, Inc. |
Methods for monitoring methotrexate therapy
|
|
ES2987915T3
(es)
|
2010-09-20 |
2024-11-18 |
Sirna Therapeutics Inc |
Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos
|
|
EP2621480B1
(en)
|
2010-09-30 |
2018-08-15 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
WO2012054365A2
(en)
|
2010-10-21 |
2012-04-26 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight cationic lipids for oligonucleotide delivery
|
|
WO2012056285A1
(en)
|
2010-10-25 |
2012-05-03 |
Fresenius Kabi Oncology Ltd. |
An improved process for the preparation of pemetrexed
|
|
WO2012061469A2
(en)
|
2010-11-02 |
2012-05-10 |
Sicor Inc. |
Crystalline forms of pralatrexate
|
|
SG189957A1
(en)
|
2010-11-05 |
2013-06-28 |
Morphotek Inc |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
|
DK2635265T3
(en)
|
2010-11-05 |
2018-07-16 |
Sirna Therapeutics Inc |
New low molecular weight cyclic amine-containing cationic lipids for oligonucleotide delivery
|
|
US8658652B2
(en)
|
2010-12-07 |
2014-02-25 |
Chelsea Therapeutics, Inc. |
Antifolate combinations
|
|
US20140086939A1
(en)
|
2011-02-28 |
2014-03-27 |
Michael Karin |
Compositions and methods for detecting and treating cancer
|
|
PL226015B1
(pl)
*
|
2011-03-03 |
2017-06-30 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną |
Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
|
|
WO2012121682A2
(en)
|
2011-03-10 |
2012-09-13 |
National Science And Technology Development Agency |
Anti-folate antimalarials with dual-binding modes and their preparation
|
|
US8673914B2
(en)
|
2011-03-28 |
2014-03-18 |
St. John's University |
Use of phosphodiesterase inhibitors for treating multidrug resistance
|
|
EP2508894A1
(en)
|
2011-04-05 |
2012-10-10 |
Receptomon LLC |
Method for monitoring gene expression of translation and Integral/Secretory protein synthesis by magnetic resonance spectroscopy (MRS)
|
|
EP4074693A1
(en)
|
2011-06-08 |
2022-10-19 |
Translate Bio, Inc. |
Cleavable lipids
|
|
US8183227B1
(en)
|
2011-07-07 |
2012-05-22 |
Chemo S. A. France |
Compositions, kits and methods for nutrition supplementation
|
|
LT2731591T
(lt)
|
2011-07-13 |
2020-12-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomos, kuriose kartu inkapsuliuotas bisfosfonatas ir amfipatinis agentas
|
|
CN107011439B
(zh)
|
2011-07-15 |
2020-11-10 |
卫材R&D管理有限公司 |
抗叶酸受体α抗体及其应用
|
|
US20130122096A1
(en)
|
2011-11-14 |
2013-05-16 |
Silenseed Ltd. |
Compositions for drug delivery and methods of manufacturing and using same
|
|
WO2014003137A1
(ja)
|
2012-06-27 |
2014-01-03 |
旭化成メディカル株式会社 |
高アフィニティー抗体、及びその製造方法
|
|
WO2014016740A2
(en)
|
2012-07-23 |
2014-01-30 |
Fresenius Kabi Oncology Ltd. |
Improved process for the preparation of pralatrexate
|
|
ITRM20120398A1
(it)
|
2012-08-08 |
2014-02-09 |
Berlin Chemie Ag |
Procedimento di sintesi pemetrexed e suo sale di lisina.
|
|
US20140120157A1
(en)
|
2012-09-19 |
2014-05-01 |
Georgetown University |
Targeted liposomes
|
|
WO2014046630A1
(en)
|
2012-09-19 |
2014-03-27 |
Keskin, Dilek |
Tumor targeted liposomal drug delivery system
|
|
CN104884617B
(zh)
|
2012-12-07 |
2019-02-19 |
协和发酵麒麟株式会社 |
抗folr1抗体
|
|
CN103040748B
(zh)
|
2012-12-18 |
2014-07-02 |
海南圣欣医药科技有限公司 |
一种培美曲塞二钠脂质体注射剂
|
|
US9192609B2
(en)
|
2013-04-17 |
2015-11-24 |
Hedgepath Pharmaceuticals, Inc. |
Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors
|
|
EP2997044A4
(en)
|
2013-05-14 |
2017-03-22 |
ImmunoGen, Inc. |
Anti-folr1 immunoconjugate dosing regimens
|
|
US20160228573A1
(en)
*
|
2014-08-14 |
2016-08-11 |
L.E.A.F. Holdings Group Llc |
Liposome encapsulated affinity drug
|
|
JOP20170004B1
(ar)
|
2016-01-15 |
2022-09-15 |
Lilly Co Eli |
الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته
|
|
AU2017258415B2
(en)
|
2016-04-29 |
2023-03-30 |
Cornell University |
Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors
|
|
US20180236098A1
(en)
*
|
2016-08-12 |
2018-08-23 |
L.E.A.F. Holdings Group Llc |
Alpha and gamma-d polyglutamated antifolates and uses thereof
|
|
KR102584446B1
(ko)
|
2016-08-12 |
2023-10-04 |
엘.이.에이.에프. 홀딩스 그룹 엘엘씨. |
알파 및 감마-d 폴리글루타메이트화 항엽산 및 이의 용도
|
|
WO2018031979A1
(en)
*
|
2016-08-12 |
2018-02-15 |
L.E.A.F. Holdings Group Llc |
Alpha and gamma-d polyglutamated antifolates and uses thereof
|
|
EP3706801B1
(en)
|
2017-11-08 |
2026-01-14 |
L.E.A.F Holdings Group LLC |
Platinum complexes and uses thereof
|
|
WO2019157148A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated antifolates and uses thereof
|
|
EP3749317A4
(en)
|
2018-02-07 |
2022-06-22 |
L.E.A.F Holdings Group LLC |
PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES
|
|
US12246019B2
(en)
|
2018-02-07 |
2025-03-11 |
L.E.A.F. Holdings Group Llc |
Alpha polyglutamated lometrexol and uses thereof
|
|
US12246018B2
(en)
|
2018-02-07 |
2025-03-11 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated pemetrexed and uses thereof
|
|
JP7491573B2
(ja)
|
2018-02-07 |
2024-05-28 |
エル.イー.エー.エフ. ホールディングス グループ エルエルシー |
アルファポリグルタミン酸化メトトレキセートおよびその使用
|
|
WO2019157129A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Alpha polyglutamated pralatrexate and uses thereof
|
|
CA3090384A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Alpha polyglutamated aminopterin and uses thereof
|
|
CA3090391A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated raltitrexed and uses thereof
|
|
WO2019157146A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Alpha polyglutamated antifolates and uses thereof
|
|
WO2019157133A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Alpha polyglutamated raltitrexed and uses thereof
|
|
JP7514533B2
(ja)
|
2018-02-07 |
2024-07-11 |
エル.イー.エー.エフ. ホールディングス グループ エルエルシー |
アルファポリグルタミン酸化テトラヒドロ葉酸およびその使用
|
|
US12290518B2
(en)
|
2018-02-14 |
2025-05-06 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated methotrexate and uses thereof
|
|
US12048767B2
(en)
|
2018-02-14 |
2024-07-30 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated pralatrexate and uses thereof
|
|
CA3090875A1
(en)
|
2018-02-14 |
2019-08-22 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated lometrexol and uses thereof
|
|
CA3090943A1
(en)
|
2018-02-14 |
2019-08-22 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated aminopterin and uses thereof
|
|
JP7442822B2
(ja)
|
2018-02-14 |
2024-03-05 |
エル.イー.エー.エフ. ホールディングス グループ エルエルシー |
γポリグルタミン酸化テトラヒドロ葉酸およびその使用
|
|
CA3149914A1
(en)
|
2019-08-06 |
2021-02-11 |
L.E.A.F. Holdings Group Llc |
Processes of preparing polyglutamated antifolates and uses of their compositions
|